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Summary 
Bone marrow presents an attractive option for the treatment of articular cartilage defects as it is 
readily accessible, it contains mesenchymal progenitor cells which can undergo chondrogenic 
differentiation, and coagulated it provides a natural scaffold that contains the cells within the 
defect. This study was performed to test whether an abbreviated ex vivo protocol that utilizes 
vector-laden coagulated bone marrow aspirates for gene delivery to cartilage defects may be 
used for clinical application. Ovine autologous bone marrow was transduced with adenoviral 
vectors containing cDNA for GFP or TGF-β1. The marrow was allowed to clot forming a gene 
plug and implanted into partial-thickness defects created on the medial condyle. At 6 months the 
quality of articular cartilage repair was evaluated using histological, biochemical and 
biomechanical parameters. The results of the repair assessment showed that the groups treated 
with constructs transplantation contained more cartilage-like tissue than the untreated controls. 
Improved cartilage repair was observed in groups treated with unmodified bone marrow plugs 
and Ad.TGF-β1 transduced plugs, but the repaired tissue from TGF treated defects showed 
significantly higher amounts of collagen II (p<0.001).  The results confirmed that the proposed 
method is fairly simple and a straightforward technique for the application in clinical settings. 
Genetically modified bone marrow clots are sufficient to facilitate articular cartilage repair of 
partial thickness defects in vivo. Further studies should focus on improvement of the combination 
of different genes to promote more natural healing. 
 
Key words: adenovirus – articular cartilage defects – transforming growth factor-β1 – bone 
marrow – cell transplantation – gene therapy       
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Introduction 
Hyaline cartilage in adults is highly specialized tissue and its unique three-dimensional 
structure enables it to withhold tremendous mechanical forces inflicted during joint movement, 
and its smooth surface lowers friction between articular surfaces of the joint. Hyaline cartilage is 
avascular, aneural and alymphatic tissue with low number of cells imbedded into extracellular 
matrix, and therefore it has very modest reparative and regenerative capabilities. Articular 
cartilage defects are very frequent, especially among younger and working population. Such 
defects do not heal, and often, with time they lead to premature osteoarthritis, and consequently a 
decrease in quality of life and increase in costs of health care. 
Both, for scientist and treating clinicians, the restoration of damaged cartilage remains 
one of the biggest challenges in modern orthopaedics. There is no pharmacological treatment that 
promotes the repair of the cartilage, and numerous clinical and experimental procedures that 
have been utilized result in fibrocartilage repair tissue that is inferior to normal cartilage.1 
Current treatment modalities include microfracture, transplantation of ostechondral grafts and 
chondrocytes, use of biodegradable scaffolds or combination of these.2,3 Although mentioned 
procedures produce good clinical result in terms of pain relief and improvement of joint function, 
long-term outcomes are less predictable and satisfactory.  
New biological approaches to cartilage repair offer alternative to current treatment 
options, particularly those that are based on the use of cells and molecules that promote 
chondrogenesis or/and inhibit cartilage breakdown.4 Any successful strategy that attempts to 
repair hyaline cartilage defects must include sufficient number of cells, appropriate signal to 
modulate cellular response and a scaffold that would contain the cells within the defect. 
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Mesenchymal stromal cells (MCSs) present very attractive option for cell-based strategies since 
they can be easily isolated, expanded, and under appropriate conditions, differentiated into 
mesenchymal tissues such as cartilage, bone or muscle.5 Numerous gene products such as 
transforming growth factor- β (TGF-β)6, bone morphogenetic protein-7 (BMP-7)7, insulin-like 
growth factor-1 (IGF-1)8 and bone morphogenetic protein-2 (BMP-2)9, have shown promises in 
regulating the process of growth, repair and regeneration of cartilage in animal models, but their 
use is limited by delivery problems and rapid clearance from the joint.  
Gene therapy has become attractive alternative system for delivering therapeutic gene 
products to specific designated tissues, which may overcome some of the mentioned 
problems.11,12 Viral vectors have been successfully used to target graftable articular 
chondrocytes, periosteal cells and bone marrow-derived MCSs as a chondroprogenitors, as well 
as the synovial lining.13,14 The use of scaffolds in cartilage repair is a very promising strategy 
since they contain, deliver and orient cells within their three-dimensional structure. Many 
different types have been tested in clinical and experimental settings, but the search for the 
optimal one is still ongoing.10   
 Ex vivo or indirect approach is usually utilized in the treatment of cartilage defects with 
genetically modified cells. It includes harvesting and expansion of the cells, transduction with a 
therapeutic gene, seeding on the scaffold and reimplantation into the defect. This approach is 
technically demanding, expensive and requires at least two surgical procedures. Pascher et al.15 
have recently proposed a novel gene transfer protocol for the repair of articular cartilage. It is an 
abbreviated ex vivo protocol that utilizes vector-laden coagulated bone marrow aspirates (gene 
plugs) for gene delivery to cartilage defects. The study showed that nucleated cells within fresh 
autologous bone marrow aspirates may be successfully transduced with adenoviral vectors 
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sufficient to secret transgene products up to 21 days. In theory, this approach provides all 
necessary ingredients for successful cartilage repair: transduced mononuclear cells secrete 
signals which stimulate mesenchymal progenitors to differentiate along the chondrogenic lineage 
The bone marrow clot itself provides a natural autolougus three-dimensional scaffold to be used 
for containment of cells and vectors within the defect and guaranties biological ingrow of the 
construct in the defect. 
To examine whether direct implantation of genetically modified bone marrow clots (gene 
plugs) might be used in situations that closely mimic real-life clinical situations, a sheep model 
was established. Partial-thickness chondral defects were created on the weight-bearing surface of 
the femoral condyle in sheep. Fresh autologous bone marrow aspirates were transduced with 
adenoviral constructs carrying therapeutic or marker genes, and the clots were pressfit implanted 
in the defect. The objectives of the current study were to: 1) determine feasibility of the proposed 
abbreviated ex vivo protocol to be used as a novel treatment tool in clinical settings, 2) to 
determine whether transgene expression of TGF-β1 within the gene plug enhances cartilage 
repair, and 3) to test whether there is a presence of adenoviral genome within the cells of 
synovial lining, which would suggest vector leakage from the clots. 
 
Results 
Histological assessment  
 The mean scores of the histological assessment are shown in Table 1 and the 
representative histological sections are shown in Figure 1. Six months after the surgical 
procedure, all groups treated with bone marrow clot transplantation were superior to empty 
control in terms of overall score according to the ICRS Visual Histological Assessment Scale, 
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although statistical significance was not observed (p=0.061) (Table 1). Each histological 
parameter was analyzed by Kruskal-Wallis test. Statistical significant difference was observed in 
one category - cell distribution: TGF and BMC groups had a higher score than  the CON group 
(Table 1).    
  
Biochemical properties 
GAG analysis did not reveal any statistical difference between the mean values for 
repaired cartilage in treatment groups and native cartilage from contralateral knee (p>0.050 for 
all comparisons paired samples t-test; Figure 2a). There were no statistically significant 
differences in GAG mean values for repaired cartilage between the treatment groups (F2,19=0.6, 
p=0.581, one-way ANOVA; Figure 2a). 
The collagen type I content was found to be significantly higher in all treatment groups 
when compared to native cartilage (p<0.050 for all comparisons, paired samples t-test; Figure 
2b). The three treatment groups also significantly differed in collagen type I content of repaired 
cartilage (F2,19=13.9, p<0.001, one-way ANOVA; Figure 2b). The collagen type I content in 
BMC group was significantly lower from that detected in GFP and TGF treated groups 
respectively (p<0.001 and p=0.001, respectively, Tukey post-hoc test), while there was no 
difference among GFP and TGF groups (p=0.482, Tukey post-hoc test). 
The collagen type II content was significantly lower in BMC and GFP treatment groups 
when compared to native cartilage (Figure 2c). There was no difference between the GFP and 
BMC groups (p=0.079, Tukey post-hoc test). Collagen type II content in the TGF group was 
significantly higher (F2,19=56.2, p<0.001, one-way ANOVA; Figure 2c) than that detected in GFP 
and BMC treated groups (p<0.001 for both, Tukey post-hoc test)  
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When compared to native cartilage, water content in the repaired tissue was significantly 
lower in the TGF and GFP groups (p<0.001 and p=0.005 respectively, paired samples t-test; 
Figure 2d)  where as the water content of the TGF group was significantly lower than the one 
detected in the GFP (F2,19=5.9, p=0.01, one way ANOVA; Figure 2d) and the BMC group 
(p=0.008, Tukey post-hoc test). 
 
Biomechanical properties 
Cartilage stiffness at micrometer scale 
Dynamic elastic modulus E* values for native articular cartilage and reparative cartilage 
obtained after the treatment with genetically modified bone marrow are shown in Figure 3. The 
measurements are obtained with microspherical tip, nominal radius of 7.5 μm, and they reflect 
structural changes at the micrometer scale. Dynamic elastic modulus E*micro values gradually 
increased from native cartilage, to the TFG, BMC and GFP treated group (Figure 3). E*micro was 
significantly higher in all repair groups when compared to native cartilage (BMC p<0.001, GFP 
p=0.003, TGF p<0.001 respectively, paired samples t-test). Treatment groups significantly 
differed in E*micro (F2,19=5.3, p=0.015; one-way ANOVA). E*micro in the TGF group was 
significantly lower than that detected in the GFP group (p=0.014, Tukey post-hoc test). E*micro 
values of the TGF group were also lower compared to values of the BMC and GFP groups but no 
statistically significant differences were observed.  
Dynamic elastic modulus E*micro was moderately positive associated with water and 
moderately negative with collagen type II, but not with GAG and collagen type I content (Table 
2).   
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Cartilage stiffness at nanometer scale 
 Dynamic elastic modulus E* values for native articular cartilage and reparative cartilage 
obtained after the treatment with gene plugs are shown in Figure 4. The measurements are 
obtained with sharp pyramidal tip, nominal radius of 20 nm, and they reflect structural changes 
at the nanometer scale. Obtained dynamic elastic modulus E*nano values showed that the BMC 
treated group had very similar stiffness to the native cartilage (p=0.345, paired samples t-test), 
but it was higher in TGF and GFP treated groups (p=0.028 and p=0.005 respectively, paired 
samples t-test; Figure 4). Furthermore, we found statistically significant difference in E*nano 
between treatment groups (p<0.001, Kruskall-Wallis test). Stiffness was significantly higher in 
the GFP control group than in the TGF group (p=0.007, Mann-Whitney test). BMC had lower 
E*nano when compared to GFP and TGF (p=0.001 and p=0.004 respectively, Mann-Whitney 
test).  
E*nano was strongly positively associated with collagen I and moderately negatively with 
water, but not with GAG and collagen II content (Table 2).   
 
PCR analysis 
To determine the expression levels of the respective vectors driven by cytomegalovirus 
promoter within the synovial membrane 6 months following surgery, PCR was performed using 
the CMV promoter and sheep β-actin primer sets. The analysis included 5 groups of specimens 
according to treatment, namely TGF-β1 vector treated, GFP vector treated as a positive control, 
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bone marrow treated, empty defect group and controls from contralateral knee. PCR analysis of 
the synovial tissue revealed no presence of CMV promoter in all of the treatment groups and the 
control group 180 days following implantation. Expression of the β-actin gene was detected in 
all of the analyzed samples. 
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Discussion 
  It is a well known fact that the healing of focal lesions in adult articular cartilage is very 
limited and, over time, they may progress to osteoarthritis. Articular cartilage damage is a 
growing health care problem and a recent study showed that approximately 2/3 of patients 
undergoing knee arthroscopies have been diagnosed with cartilage lesion.16 On the other hand 
growing armamentarium of novel biological methods and technologies offer scientists as well as 
clinicians powerful tools in developing new and effective methods in treating damaged cartilage. 
Cell based therapies, signaling and scaffolds are key topics on which any successful tissue-
engineering strategy builds.17  
 The approach to cartilage repair of local defects described in this study utilizes vector-
laden coagulated bone marrow aspirates for gene delivery to cartilage defects. Aspirated 
autologous bone marrow contains progenitor cells, the matrix is completely natural and native to 
the host, and the contained fibrin fibers adhere the whole construct to the surface of the defect. 
Preliminary in vitro and in vivo studies on small animals showed that clotted mixtures of 
adenoviral suspensions with fresh aspirated bone marrow resulted in levels of transgenic 
expression in direct proportion to the density of nucleated cells within the clot.15 The current 
study is a step forward towards a clinical application of genetically modified bone marrow (gene 
plugs) to treat local cartilage lesions. The whole study was conceived in a way to simulate 
potential clinical situation where one would have to treat isolated chondral defect situated on the 
load-bearing surface of the femoral condyle. Therefore a sheep model as a large animal model 
was chosen. The drawback of the proposed model is the fact that sheep cartilage on the medial 
condyle is very thin. Ahern et al. performed a detailed systematic review of preclinical animal 
models in single site cartilage defect testing, and according to their analysis the ovine cartilage is 
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variable in thickness and it measures from 0.40 to 1.68 mm.18 Minor variability in the obtained 
results might be contributed to that fact, nevertheless, reproducible standardized chondral defects 
could be created in all animals, using a adapted punch-drill device. For implantation of the gene 
plugs standard operation instruments were used. The proposed method proved to be fairly simple 
and a straightforward technique for application in clinical settings. It is a single step operation, 
which can be easily done by two surgeons within 30 to 45 minutes.   
  
The use of TGF-β1-transduced bone marrow clots for articular cartilage defects repair 
Adult MSCs present a very interesting platform for the development of treatment 
strategies in orthopaedic tissue engineering. They can be obtained relatively easily from various 
tissue sources such as bone marrow, fat and muscle, and under appropriate conditions they have 
the capacity of differentiation into various mesenchymal lineages including bone and 
cartilage.5,19 Numerous in vitro studies showed that primary MSCs undergo chondrogenic 
differentiation when cultured in the presence of specific media supplements, including 
dexamethasone and certain extracellular biological cues.20,21  
TGF-β1 has been used as a key stimulator of chondrogeneseis in many in vivo and in 
vitro studies, as it stimulates cell proliferation and synthesis of major components of extracellular 
matrix (ECM) - GAG and collagen.22,23,24 TGF-β1 was chosen because it is one of the best 
characterized and the most potent chondrogenic growth factors. The results of the present study 
showed that all groups that underwent transplantation of bone marrow clots have a high content 
of GAGs, but only the repair tissue of TGF-β1 gene plug treated defects had a very high content 
of collagen type II similar to native cartilage. The fact that only TGF treated defects scored 
statistically higher in terms of cellular distribution leads to the conclusion that residing 
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mesenchymal progenitors within the gene plug responded to the local expression of TGF-β1 in 
terms of chondrogenic differentiation, which in the end resulted in higher ECM turnover and 
better quality of the cartilage repair. Guo et al.25 reported similar results in a rabbit model of full-
thickness cartilage defects using an ex vivo approach and a chitosan scaffold. Another study by 
Pagnotto et al.26 showed improved cartilage repair in osteochondral defects implanted with 
MSCs transduced with adeno-associated virus (AAV) carrying cDNA for TGF-β1. In their study 
transgene expression slowly decreased from 100% at two weeks to 17% at 12 weeks, but it 
proved that gene therapy enables sustained delivery of the bioactive molecules for a period of 
time that is sufficient to induce and govern cellular response within the defect. Owing to its safe 
profile, AAV is considered to be the most suitable viral vector for human application, and is 
currently being tested in phase I clinical trial.27  
Although practical, the use of a single biological factor to stimulate and regulate process 
of chondrogenic differentiation has obvious limitations in ability to produce cartilage of optimal 
quality. Chondrogenesis is a finely regulated mechanism, which includes numerous growth and 
transcription factors, and a combination of these might be more effective. Synergistic effect on 
chondrogenesis has been reported for TGF-β1 when co-administered with IGF-1.28 Steinert at 
al.29 recently used aggregate culture system to study effects of co-expression of TGF-β1, IGF-1 
and BMP-2 on MSCs. Their results showed larger aggregates, higher levels of GAG synthesis, 
and greater expression of cartilage specific marker genes by adding different combinations of 
growth factors to MSCs.  Furthermore, it is known that TGF stimulation of MSCs promotes 
hypertrophy and the increased expression of collagen type I and X. However, Kafienah et al.30 
have shown that including parathyroid hormone-related protein (PTHrP), down-regulates 
collagen type I and X in cartilage tissue engineered from MSCs.  It should be also noted that 
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some transcription factors such as SOX-9 (which is known to be essential for the full expression 
of chondrocyte phenotype) and Wnt are not chondrogenic itself, but can make cells more 
responsive to growth factors and other chondrogenic stimuli. Along these lines, in order to 
optimize the proposed method, delivery of multiple genes might be more reliable option, and 
further studies are needed to pinpoint the exact protocol in terms of concentration and temporal 
sequence of delivery of chosen genes.  
Apart from the fact that in the current study only TGF-β1 was used to induce 
chondrogenesis, another important drawback is the fact that we were not able to control weight-
loading conditions in operated animals. Inconsistencies in repair quality in between the treated 
groups could be attributed to the influence of the weight-loading conditions of the joint 
immediately after the surgical procedure. In human patients proper rehabilitation protocols are 
crucial to optimize the results of bone marrow-stimulating as well as cell based techniques, 
including postoperative continuous passive motion exercises along with crutch-assisted 
restrictions of weight-bearing up to 6 to 8 weeks.31,32 Practical limitations prevented 
postoperative ambulation restrictions, possibly inflicting detrimental shear forces on the 
construct, leading to a reduced quality of produced matrix. In our study these limitations might 
be reflected in the fact that TGF treated groups have good concentrations of GAGs and collagen 
II, but very high content of collagen I and low content of water.  
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Determining biomechanical properties of cartilage repair tissues by indentation-type atomic 
force microscopy (IT AFM) 
 
Biochemical and histological parameters provide information regarding the amount and 
spatial distribution of the major components comprising repaired cartilage. However, only 
biomechanical analysis can assess the load-bearing capabilities of the cartilage and therefore 
biomechanical parameters reflect the true nature of the repaired tissue. To determine load-
bearing capabilities of examined tissue, IT AFM was used to determine stiffness - a mechanical 
parameter that describes the relation between an applied, nondestructive load and resultant 
viscoelastic deformation of cartilage tissue. Furthermore, biomechanical data with biochemical 
content was correlated.  
Hyaline cartilage is highly specialized tissue with unique three-dimensional structure, 
which allows it to behave mechanically as viscoelastic solid.33 It reflects unique ultrastructure of 
cartilage extracellular matrix composed of proteoglycans embedded into a network of different 
types of collagen fibrils. Furthermore, under cyclic loading, the applied stress and resulting strain 
are not in phase. In order to determine stiffness of the cartilage, compressive force is applied and 
the ratio of stress to strain – dynamic elastic modulus E* is calculated. Several studies describe 
use of differently shaped probes for indentation testing of cartilage where data are typically 
assessed at millimeter scale. However, this is insufficient to detect local mechanical property 
variations of the examined tissue that reflect differences in cartilage structural organization at the 
molecular level. 34,35  
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To overcome these limitations, Stolz et al.36 proposed a novel, AFM-based approach they 
termed IT AFM. Their protocol enabled absolute measurements of the dynamic elastic modulus 
E* at two different length scales of tissue organization – micrometer and nanometer scale. This 
is technically possible because two different probe types are used for these measurements: the 
microspherical tips for micrometerscale measurements and sharp pyramidal tips for 
nanometerscale measurements. In our study dynamic elastic modulus E*nano of the native sheep 
cartilage is approximately 0.02 MPa, and E*micro is ~1 MPa, which is in agreement with studies 
performed on the healthy human cartilage, where stiffness values averages around 0.015 MPa, 
and 2.6 MPa respectively for healthy individuals without OA.37,38. According to Stolz et al., this 
100-fold modulus difference between micrometer and nanometer scale is a result of assessing 
different levels of cartilage hierarchical organization. On the micrometer scale, articular cartilage 
behaves as relatively amorphous material while at the nanometer scale ultrastructural differences 
are resolved.  
Microstiffness values were lowest for native cartilage and gradually rose from TGF and 
BMC to GFP treated groups respectively (Figure 3). This would suggest that the repair tissue of 
the TGF treated group is qualitatively superior to the other two groups showing biomechanical 
properties close to native cartilage. However, nanoscale measurement showed that the BMC 
treated group has very similar nanostiffness to that of native cartilage, and the stiffness values of 
the TGF and GFP treated groups are much higher (Figure 4). We hypothesized that this 
observation could reflect different amount and spatial orientation of newly synthesized 
extracellular components and/or amount of water within the repair tissue in the last two groups. 
To test this hypothesis correlation analysis was performed which showed that the dynamic elastic 
modulus E*micro correlated moderately positively with water and moderately negatively with 
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collagen type II, but not with GAG and collagen type I content (Table 2). At the same time 
E*nano correlates strongly positive with collagen type I and moderately negative with water, but 
not with GAG and collagen type II content (Table 2). At micrometer level, biomechanical 
properties of cartilage repair tissue are only moderately correlated with the biochemical content. 
This observation leads us to conclusion that, at micrometer level of tissue organization, it is not 
possible to determine contribution of individual ECM components to biomechanical properties 
of repaired cartilage. However, at nanometer level dynamic elastic modulus correlates with 
collagen I content, which is barely present in native cartilage. A sharp AFM tip has nominal 
radius of 20 nm that is smaller than an individual collagen fibril, which typically measures 
around 50 nm.36 While microspherical tip is too big to detect subtle differences in orientation and 
amount of collagen fibrils, sharp pyramidal tip can discriminate such differences, resulting in 
higher stiffness values.  
 
 
Presence of adenoviral vector in the surrounding synovial lining   
The use of viral-based gene therapy has always raised lot of controversies regarding its 
safety. Although very effective in terms of gene transfer and expression, viral vectors induce 
immune response and their presence in the surrounding tissue may result with detrimental side 
effects For example TGF-ß1 if administered into the joint in higher concentration leads to 
chondrophyte formation at the margins of the joint, which at later stages calcify and become real 
osteophytes.39 One of the major goals of this study was to determine if there is any residual 
presence of virus within the synovium.  Following sacrification of the animals, joints were 
inspected for any signs of osteophyte formation and/or arthrofibrosis, but none were detected. 
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PCR analysis of the synovial lining tissue could not detect residual presence of the vectors in any 
of the experimental groups, which suggests that the virus is well contained within the clot, and 
there is no leakage to the surrounding tissue, consistant to previous studies from Pascher et al.15 
in rabbits.  
In conclusion, the present study systematically explores benefits and pitfalls of the novel 
technique to treat local cartilage defects by using gene plugs in clinical settings. Contrary to 
more complex approaches in tissue engineering we advocate the use of simpler methods that 
harness the intrinsic regenerative potential of endogenous tissues using biological stimuli to 
initiate and promote natural healing in situ. This concept has been termed facilitated endogenous 
repair by Evans et al.40 and the ultimate goal is to enable clinicians to use tissue engineering that 
is not only successful but also cheap, safe and clinically expeditious. The proposed method is a 
single-step procedure that can be easily implemented in standard clinical settings, avoids usual 
drawbacks associated with gene therapy because administered locally, and avoids the use of 
expensive in vitro production of autologous and engineered tissues.  
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Materials and methods 
Vector Construction 
The first generation recombinant vector used in this study originated form replication-
deficient type 5 adenovirus lacking E1 and E3 loci (Ad.).41 The recombinant Ad.TGF-β1 and 
Ad.GFP were constructed by Cre-lox recombination using the system of Hardy et al.42 Briefly, 
the adenoviral vectors were propagated in 293-CRE8 cells and purified on three successive 
CsCl2 density gradients between 1.2 and 1.4 g/ml. Following dialysis in 10mM Tris-HCL, pH 
7.8, 150mM NaCl, 10mM MgCl2 and 4% sucrose, the preparations were aliquotted and stored at 
-80°C. Viral titers were estimated by optical density and standard plaque assay. 
 
Animals 
Twenty eight skeletally mature sheep (female, 1 to 3 years old) were used for this study. 
The sheep were randomly assigned to one of four groups. In the bone marrow clot group (BMC) 
(n=6), the sheep were implanted with untreated autologous bone marrow clot that was aspirated 
from iliac crest of respected animal. In the green fluorescent protein group (GFP) (n=6) 
autologous bone marrow clots genetically modified with Ad.GFP (GFP gene plug) to express 
green fluorescent protein were implanted in sheep as a positive control. In the TGF-β1 treated 
group (TGF) (n=10) autologous bone marrow clots genetically modified to over express 
transforming growth factor-β1 (TGF-ß1 gene plugs) were implanted in the sheep. In the negative 
control group defects were left empty (n=6) (CON, defect without implant). Native cartilage 
from the contralateral knee was harvested from each animal and compared to the repair tissue of 
the defect sites. The experimental protocol was approved by the local Animal Experiment Ethical 
Committee. 
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Anesthesia Protocol  
The sheep were operated on under general anesthesia and aseptic conditions. The 
premedication was performed with 0.1 mg/kg of intramuscular xylazine (Xylapan, Vetoquinol, 
Bern, Switzerland) and cephalic vein was prepared for administration of drugs. Induction of 
anesthesia was performed intravenously with 2.5% solution of thiopentale sodium (Thiopental, 
Nycomed, Ismaning, Germany) in a dose 5 mg/kg and small boluses of drug were administered 
until the jaws were relaxed for endotracheal intubation. Cefuroxime (Ketocef, Pliva, Zagreb, 
Croatia) was administered perioperatively. Carprofen (Rymadil, Pfizer Animal Healthcare, 
Exton, PA, USA) was administered postoperatively in a dose of 2 mg/kg. 
 
Surgical Procedure  
Medial parapatellar arthrotomy was performed on the right knee of each animal, and both 
condyles were exposed. A standardized partial-thickness chondral defect of 6.2 mm in diameter 
(Fig 5a and 5b) was made on the weight-bearing surface of the medial condyle using an adapted 
punch-drill device of an mosaicplasty instrumentary (Smith & Nephew Inc., Andover, MA, 
USA). Special care was taken not to damage the subchondral bone, as well as to create sharp 
edges as the boder of the defects, perpendicular to the joint surface. Defects were then treated as 
described below. 
 
Pressfit implantation of gene plugs and native bone marrow plugs into the defects  
 Under sterile surgical conditions 3 ml of bone marrow was aspirated form the right iliac 
crest of an anesthetized sheep using Trapsystem®Set (H-S Medical, Inc., Boca Raton, FL, USA) 
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or a 16g needle. Using a 1-ml micropipette, aliquots of 250 ml were rapidly mixed with 25µl 
suspension of 1 x 1010 viral particles of Ad.GFP or Ad.TGF-β1. The mixtures were pipetted into 
the defects being covered with a paper to build a chamber and allowed to coagulate in situ for 
five minutes. The paper was then removed, the implants rinsed with saline solution and checked 
for stability by repetitive flexion and extension of the knee. The joint was closed by suturing in 
two layers (Fig 5c,d). 
 
Harvesting the samples 
All sheep were euthanatized by intravenous injection of an overdose of barbiturate 6 
months after surgery. The medial condyle containing the cartilage defect was removed and 
divided into two halves using a cooled saw, one being used for histology and one for 
biochemistry and biomechanical testing. Undamaged articular cartilage was taken from the 
medial condyle of the contralateral knee joint for control. The specimens for histology, 
biochemical and biomechanical analysis were prepared as described below. Synovial lining 
specimens were taken from each joint and stored in liquid nitrogen for PCR analysis.  
 
Morphologic Analysis—Histology 
The osteochondral samples fixed for histology were decalcified in 10% EDTA. The 
samples were dehydrated in alcohol, embedded in paraffin, and sectioned at 5 µm. Sections were 
stained with hematoxylin and eosin to evaluate morphology, and safranin-O to assess 
proteoglycan distribution in the pericellular matrix. Slides were examined blinded by two 
observers by light microscopy and graded semi-quantitatively using the ICRS Visual 
Histological Assessment Scale.43 The scoring system was based on articular surface morphology, 
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matrix composition, cellular distribution, cell population viability, subchondral bone morphology 
and cartilage mineralization. 
 
Quantitative Biochemical Characterization 
Samples were frozen and stored at -80°C until ready for analysis. Wet and dry weights of 
the cartilage or repair tissue were determined before and after freeze-drying. The samples were 
then solubilized using digestion with trypsin and processed for complete biochemical analysis, as 
described by Dickinson et al.44 
Each sample was milled in liquid nitrogen using a stainless steel percussion mortar and 
pestle, to obtain a fine particulate, and weighed after freeze-drying to obtain the dry weight.  
Bovine pancreatic trypsin was prepared at 2 mg/mL in Tris buffer (pH 7.5), containing 1mM 
iodoacetamide, 1mM ethylenediaminetetraacetic acid and 10 mg/mL pepstatin A (all from 
Sigma). An initial incubation for 15 h at 37°C with 250 mL trypsin was followed by further 2h 
incubation at 65°C after the addition of a further 250 mL of the freshly prepared proteinase. All 
samples were boiled for 15 min at the end of incubation, to destroy any remaining enzyme 
activity. 
Type I collagen. The digests were assayed using inhibition enzyme-linked 
immunosorbent assay (ELISA) using a rabbit antipeptide antibody to type I collagen, as 
previously described. 
 Type II collagen. The digests were assayed using inhibition ELISA using a mouse 
immunoglobulin G monoclonal antibody to denatured type II collagen, COL2–3/4m, as 
previously described, but modified for use on 384-well plates to allow the use of a smaller 
volume of sample than is required for a 96-well plate.19  
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Glycosaminoglycans (GAG). A previously described colorimetric assay for GAG was 
modified for use on 384-well plates to allow the use of a smaller volume of sample than is 
required for a 96-well plate.19,45 
 Water content. The percentage of water was calculated by subtracting the dry weight of 
the sample and dividing the difference by the wet weight. 
 
Polymerase chain reaction (PCR) analysis 
To detect the presence of adenoviral genome in the synovial lining, PCR analysis was 
performed. Synovial membranes of the joints were digested with proteinase K for 4 hours at 37 
°C. Total DNA was then extracted using a DNeasy Tissue kit (Qiagen, Valencia, CA, USA), 
following the manufacturer instructions. Amplification of the CMV promoter sequence in the 
vector and the sheep β-actin gene was performed using the following primers: cytomegalovirus 
forward 5′-TCATATGCCAAGTACGCCCCC-3′, reverse 5′-TGGGGCGGAGTTGTTACGAC-
3′; β-actin forward 5′CATGCCATCCTGCGTCTGGACC-3′, β-actin reverse 5′ 
TACTCCTGCTTGCTGATCCACATCTGC-3′. Amplification products were visualized on 
agarose gel with ethidium bromide. 
 
Biomechanical properties 
Biomechanical properties of the repair tissue compared to regular cartilage from the 
contralateral knee was assessed by IT AFM of 2 mm diameter samples, harvested by using a skin 
biopsy punch and scalpel. Care was taken to include the full thickness of the repair tissue but to 
exclude any subchondral bone. The specimens were then stored in the cold room at 4º Celsius in 
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PBS supplemented with protease inhibitor cocktail (Complete, Boehringer Mannheim, 
Germany).  
Mechanical properties (i.e. stiffness) of articular cartilage and repair tissue were 
determined by measurements of |E*|, the dynamic elastic modulus of articular cartilage at two 
different length scales of tissue organization – micrometer (|E*|micro) and nanometer (|E*|nano). 
Preparation of the cartilage samples, data acquisition and processing was done as described by 
Stolz et al.36 Briefly, spherical tips with radius of 7.5 µm (SPI Supplies, West Chester, PA, USA) 
were mounted onto the end of rectangular tipples silicon nitride cantilevers having nominal 
spring constants of 0.35 N/m (MicroMasch, San Jose, CA, USA) and used for micrometer-scale 
experiments. For nanometer-scale experiments, square-based pyramidal silicon-nitride tips with 
a nominal tip radius of 20 nm on V-shaped 200-mm-long silicon nitride cantilevers with a 
nominal spring constant of 0.06 N/m (Veeco Instruments Inc., Plainview, NJ, USA) were used. 
The IT AFM was operated in the force-volume mode where the load-displacement curves were 
recorded at five different sites on the sample surface at a frequency of 3 Hz with scan areas of 0 
µm x 0 µm and 10 µm x 10 µm. Data sets recorded at any given sample site consisted of 256 
load-displacement curves (each curve consisting of 512 data points) which were analyzed to 
compute the dynamic elastic modulus |E*|. 
 
Statistics 
 A Kolmogorov-Smirnov test was used to test distributions of biochemical (GAG, 
collagen I, collagen II and water) and biomechanical data (|E*|micro and |E*|nano) for normality. 
Distributions were normal for all the variables except for |E*|nano. Therefore parametric tests to 
analyze all biochemical and biomechanical data were used, except for mentioned elastic modulus 
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data where we used non-parametric tests. Biochemical and biomechanical properties of repaired 
cartilage were expressed as the mean (M) ± standard deviation (SD). As the contralateral knee in 
each animal served as its own control, a 2-tailed paired samples t test was used to compare 
treatment versus control groups. Data from each test subsets were compared by one-way analysis 
of variance (ANOVA) with Tukey post-hoc test where required. To analyze |E*|nano we used 
Wilcoxon matched pairs test as a non-parametric equivalent of paired samples t test and Kruskal-
Wallis and Mann-Whitney tests as non parametric equivalents of ANOVA and Tukey post hoc . 
Non-parametric tests were also used to analyze semi-quantitative histological scores. Association 
between biomechanical properties and biochemical content were determined using Spearman 
correlation. Statistical significance was set at p < 0.05. All analyses were performed using SPSS 
17.0 for Windows (SPSS Inc., Chicago, IL). 
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Titles and legends to figures 
Figure 1 Representative histological sections of the repair tissue filling the ovine chondral 
defects stained with hematoxylin-eosin (left panel) and safranin-O (right panel). Panel bars: 100 
µm. (a,b) CON group showing acellular tissue (AC) within the defect with intact subchondral 
bone (BS). (c,d) BMC group. The defect is predominantly filled with fibrocartilage (FC). There 
is clear demarcation between native hyaline cartilage (Hc) and fibrocartilage (Fc) separated by a 
defect gap (DG). The subchondral bone (BS) is intact. (e,f) GFP group. Irregular filling of the 
defect with fissures. The defect is filled with mixture of hyaline and fibrocartilage. (g,h) TGF 
group. Improved histological appearance of the repair tissue within the defect. Hyaline cartilage 
(Hc) and columnar organization of chondrocytes is detected on both sides of the defect gap 
(DG).  The subchondral bone is intact (BS).      
Figure 2 Biochemical analysis of repaired cartilage compared to native cartilage. (a) GAG. (b) 
Collagen I. (c) Collagen II. (d) Water. 
* 2-tailed paired t test: comparison of repaired and  native cartilage (p<0.05) 
† 1-way ANOVA with Tukey post-hoc test: comparison of the treatment groups (p<0.05) 
 
Figure 3 Micrometer measurements. Dynamic elastic modulus E*micro of native articular 
cartilage and repair tissue of the BMC, GFP, and TGF group. Average microstiffness (M±SD) 
increased from native cartilage to GFP treated group: E*micro = 1.025  0.098 (native cartilage), 
E*micro = 1.577  0.285 (TGF), E*micro = 1.863  0.079 (BMC), E*micro = 2.025  0.371 (GFP). 
* 2-tailed paired t test comparison of repaired versus native cartilage (p<0.05) 
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† one-way ANOVA with Tukey post-hoc test comparison of repaired cartilage between 
treatment groups (p<0.05) 
Figure 4 Nanometer measurements. Dynamic elastic modulus E*nano of native articular 
cartilage and repair tissue of the BMC, GFP, and TGF group. E*nano =19.28  3 (native 
cartilage), E*nano = 21.54  1.24 (BMC), E*nano = 39.26  104.56 (TGF), E*nano = 189.21  
39.26 (GFP). 
* 2-tailed paired t test comparison of repairedand native cartilage (p<0.05) 
† one-way ANOVA with Tukey post-hoc test comparison of treatment groups (p<0.05) 
Figure 5 Implantation of a gene plug. (a) An adapted standardized mosaciplasty instrumentary 
was used to create a chondral defect on the weight-bearing surface of the medial condyle in 
sheep. (b) Care was taken not to penetrate the subchondral plate. The defect measured 6.2 mm in 
diameter. (c) Pressfit Implantation of the bone marrow construct into the defect. (d) The plug is 
stable, well-placed within the defect, joint is rinsed with saline and ready to be closed. 
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Tables 
 
Table 1 Histological grading of the repair tissue at 6 months according to ICRS Visual 
Histological Assessment Scale a (medians ± interquartile range) 
 Treatment group  
ICRS Score CON BMC GFP TGF p* 
 C Q C Q C Q C Q  
Surface 0.00 0 0.00 0 0.00 0 0.00 0 0.343
Matrix 1.50 2 3.00 1 3.00 2 3.00 0 0.062
Cell ditribution 1.00† 0 2.00 0 2.00 2 2.00 0 0.016
Cell population 
viability 0.00 1 1.00 3 0.00 0 0.00 0 0.095
Subchondral 
bone 2.50 1 3.00 0 3.00 3 3.00 0 0.177
Cartilage 
mineralization 1.50 3 3.00 0 3.00 3 3.00 0 0.162
Median total 
score 6.50 6 11.50 4 11.00 9 11.00 0 0.061
 
Abbreviations: CON, control group; BMC, bone marrow clot group; GFP, green fluorescent 
protein group; TFG, transforming growth factor-β1 group, C, median; Q, interquartile range.   
aThe table shows the medians from each group for each subcategories, and the total medians for 
each group. 
* Kruskal-Wallis test (Mann-Whitney test was used as a post-hoc procedure when K-W test 
revealed statistically significant difference). 
† Significantly lower score from TGF and BMC groups (p=0.002 and p=0.008 respectively, 
Mann-Whitney test). 
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Table 2 Associations between dynamic elastic modulus measured on micrometer and nanometer 
scale and biochemical parameters (GAG, collagen I, collagen II and water). 
 Association [Spearman's ρ(p)] 
 E*micro E*nano 
GAG -0.35 (0.108) -0.24 (0.288) 
Collagen I -0.08 (0.710) 0.80 (<0.001)† 
Collagen II -0.56 (0.007)† 0.29 (0.191) 
Water 0.44 (0.038)* -0.46 (0.033)* 
†. Association is significant at the 0.01 level (2-tailed). 
*. Association is significant at the 0.05 level (2-tailed). 
 
